Catalyst Wire Dossier Catalyst Wire Dossier

Dispervise Ophthalmic Viscoelastic

· Innovative Medical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dispervise Ophthalmic Viscoelastic, covering 2012-01-18 to 2012-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions [Phase 4]

See pricing